Eyebright Medical Technology (Beijing) Co., Ltd., commonly referred to as Eyebright Medical, is a leading player in the medical technology industry, headquartered in Beijing, China. Founded in 2015, the company has rapidly established itself as a key innovator in the development of advanced medical devices and solutions, particularly in the fields of ophthalmology and healthcare diagnostics. Eyebright Medical focuses on creating cutting-edge products that enhance patient care and streamline clinical workflows. Their core offerings include state-of-the-art diagnostic equipment and therapeutic devices, distinguished by their precision and user-friendly design. With a commitment to quality and innovation, Eyebright Medical has garnered recognition in both domestic and international markets, positioning itself as a trusted name in medical technology.
How does Eyebright Medical Technology (Beijing) Co., Ltd.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Medical Device Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Eyebright Medical Technology (Beijing) Co., Ltd.'s score of 22 is lower than 76% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Eyebright Medical Technology (Beijing) Co., Ltd. currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Consequently, there are no recorded Scope 1, 2, or 3 emissions. Additionally, the company has not established any documented reduction targets or climate pledges, which suggests a lack of formal commitments to reducing carbon emissions at this time. As the company operates within the medical technology sector, it is essential to note that many organisations in this industry are increasingly focusing on sustainability and climate action. However, without specific data or commitments from Eyebright Medical Technology, it is challenging to assess their environmental impact or future initiatives. Overall, the absence of emissions data and reduction targets highlights an opportunity for Eyebright Medical Technology to enhance its climate strategy and align with industry standards for sustainability.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Eyebright Medical Technology (Beijing) Co., Ltd. has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.
